IL-6 and IL-8 reductions in long-term studies likely reflect the central role of these cytokines in chronic low-grade inflammation, particularly in metabolic syndrome, endothelial dysfunction, and insulin resistance [5]. Here, CXCL8 is linked to metabolic syndrome.